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To measure the accuracy and quality of immunisation information systems in a 
range of low-income countries eligible to receive GAVI support.  
Methods 
The Data Quality Audit (DQA) uses a WHO validated, standard methodology to 
compare data collected from health unit (HU) records of immunisations 
administered with reports of immunisation at central level and to collect quality 
indicators of the reporting systems. The Verification Factor (VF), as a measure 
of accuracy, expresses the proportion of immunisations reported at national 
level that can be tracked down to the HU. A VF of 80% or above entitles 
countries to receive additional GAVI financial support. Quality indicators are 
assigned points which were summed to obtain quality scores (QS) at national, 
district and HU levels. 
DQAs were conducted between 2002 and 2005 in 41 countries, encompassing 
1082 primary health care units in 188 randomly selected districts. 
Results 
Almost half of countries obtained a VF below 80% and only nine showed 
consistently high VF and QS scores. The most frequent weaknesses identified 
in the information systems included: inconsistency of denominators used to 
estimate coverage, poor availability of guidelines (e.g. for late reporting), 
incorrect estimations of vaccine wastage and lack of feedback on immunization 
performance. In all six countries that failed a first DQA and undertook a second 
DQA the VF and all QSs improved, not all of them statistically significantly. 
Conclusions 
The DQA is a diagnostic tool to reveal a number of crucial problems that affect 
the quality of immunisation data in all tiers of the health system. It identifies 
good performance at HU and district levels which can be used as examples of 
best practices. The DQA methodology brings data quality issues to the top of 
the agenda to improve the monitoring of immunisation coverage. 




Routine immunisation is one of the most cost-effective public health 
interventions (The World Bank 1993) to reduce child mortality (Jones et al. 
2003). Global immunisation coverage of systematic vaccines has been steadily 
increasing since the eighties (WHO 2006). However, global figures mask great 
inequalities between geographical regions and population sectors (WHO 2006, 
Pearson 2003). It has been estimated that almost 18 million infants have not 
received the first dose of Diphtheria-Tetanus-Pertussis vaccine (DTP), half of 
them living in Southeast Asia and one third of them in Africa (Anonymous 
2006). 
The GAVI Alliance (GAVI), launched in the year 2000, is one of the global 
health partnerships that have emerged in recent years aiming at improving 
access to known effective health care interventions (Walt and Buse 2000). 
GAVI’s mission is to save children's lives and to protect people's health through 
the widespread use of vaccines (GAVIa). It focuses on the 72 countries (in 
2006) with a Gross National Income (GNI) per capita below 1,000 USD 
(GAVIc), where most of the unimmunised children live (WHO 2006). 
GAVI’s support to countries include immunisation services (ISS), injection 
safety, new and underused vaccines, health systems strengthening and civil 
society organisation support (GAVIb). ISS is provided in two phases: an 
investment phase (years one and two) and the reward phase (from year three 
onwards). During the latter, countries receive 20 USD per additional infant who 
has received DTP3 (third dose of DTP) as compared to baseline figures 
(GAVId). However, this reward is contingent to providing evidence that data 
reported by countries are reliable, as assessed with Data Quality Audits (DQA). 
The aim of any initiative to improve immunisation is to increase coverage up to 
a level where all children are protected against the targeted diseases. However, 
it has been increasingly recognised, that good quality information for decision-
making is essential to increase coverage (Papania M and Rodewald 2006, Bchir 
et al. 2006). Surveillance, monitoring and evaluation are integral components of 
successful immunisation systems (WHO/UNICEF 2005). 
DQA is a survey methodology developed by the World Health Organisation 
(WHO) which estimates the robustness of immunisation reporting systems. The 
main outcome of DQAs is the estimation of the Verification Factor (VF), which 
expresses the accuracy of the reporting system by estimating the proportion of 
DTP3 immunisations that can be traced through the reporting system, from the 
vaccine delivery points up to the national coverage estimates. GAVI partners 
agreed that countries with a VF of 80% or more would ‘pass’ and receive the 
reward while countries that ‘fail’ are required to produce their own plans to 
improve the reporting system and are encouraged to conduct a second DQA 
two years later (The LATH Consortium 2001). 
A previous paper (Ronveaux et al. 2005) reviewed the methodological issues of 
DQA and focused on the aggregated outcomes of the DQAs conducted up to 
2003. In this report, we present individual countries’ performance of the DQA 
carried out in 41 countries up to 2005, and explore patterns of performance 
among countries. We also show the changes in the reporting system in those 
countries that failed the first DQA and undertook a second one. Since DQA do 
not aim at estimating immunisation coverage, we will not do any comparison 
with other methods to estimate immunisation coverage. 




DQA is a standard methodology developed by the WHO; it is carried out by 
independent companies after an open tender process. Two external consultants 
travelled to each country and engaged with two staff members of the national 
immunisation programmes to conduct the DQAs over a period of two weeks. 
In each country, a multistage sampling procedure was followed: first, four 
districts were randomly selected with probability proportional to the reported 
doses of DTP3 administered in the previous year; secondly, in each of the four 
districts, six Health Units (HU), where immunisations are administered, were 
randomly selected (total of 24 HUs per country). This weighted representative 
sampling was designed to fit with what could be reasonably achieved within the 
resources and timeframe of the DQA. Districts and HUs with unsolvable access 
problems which make them non-eligible were excluded from the sampling 
process. Reasons for exclusion were mainly security situations or major 
geographical barriers that could not be overcome within the timeframe of a field 
visit. DQAs with a proportion of unreachable districts greater than 20% have 
been excluded from some of the analyses and indicated in the text. 
DQAs have two outcome measures: the VF and the Quality Scores (QS). The 
period audited was the full calendar year previous to the date when the DQA 
took place. 
In each district, the VF is calculated by dividing the number of DTP3 
vaccinations administered during the audited year as recounted in the HUs 
records filled at the very moment when children are vaccinated by the annual 
DTP3 vaccinations reported in the HUs reports found at the health district 
offices (the usual next tier in the reporting system). This quotient is adjusted for 
the weight of the six selected HUs in relation to the whole number of HUs in the 
district. This is finally extrapolated to the national level as the weighed average 
of districts VFs. The methods and mathematical expressions have been 
described in detail elsewhere (Ronveaux et al. 2005, WHO 2003).  
A VF less than 100% indicates that the reports at district level showed more 
DTP3 administrations than those that could be recounted at HU level (‘over-
reporting’); a VF over 100% suggests that not all DTP3 doses recounted could 
be traced in the reports at district level (‘under-reporting’). 
QSs were based on a series of questions and observations undertaken at each 
level of the immunisation programme: national, district and HU. They covered 
topics such as recording and reporting of immunisation data, keeping of vaccine 
ledgers and information system design. Each question correctly answered was 
assigned one point. An average QS ranging from 0 to 5 was obtained for the 
national level, for each one of the four districts and for each one of the 24 HUs 
(some questions for each level of the system differed).  
Finally, auditors provided feed-back to immunisation staff at all levels and 
suggested recommendations addressing the most relevant issues identified. 
Statistical analyses 
Summary Quality Scores for each level are presented as medians and inter-
quartile ranges of the QS estimated for each country, district and HU.  
Correlation between continuous variables was estimated using Spearman’s 
rank test since we could not assume that their errors followed a normal 
distribution.  Differences between medians were tested using the Mann-Whitney 
test in SPSS 13.0 (SPSS Inc. 1989-2004). 





Forty seven DQAs were conducted between 2002 and 2005 in 41 countries: 30 
African, 9 Asian, 1 Middle-Eastern and 1 Caribbean. 21 countries failed the 
DQA (VF less than 80%), and six of those conducted a second DQA (total 47 
DQAs). 
The proportion of non-eligible districts for sampling was higher than 20% in nine 
of the 41 DQAs: 55% in Yemen, 45% in Nepal, 43% in Myanmar, 41% in 
Congo, 34% in Afghanistan, 32% in Lesotho, 32% in Sudan’s second DQA, 
25% in DR Congo and 22% in Mali. A total of 1,082 HUs were surveyed in 188 
districts in the 47 DQAs. Table 1 summarises the country profiles and DQA 
framework. 
The VF (data accuracy) was below the threshold value (80%) in 46% of the 
DQAs (median of the VF 83%, inter-quartile range (IQR) 23%) (Figure 1). 
Excluding those DQAs with high proportion of unreachable districts: 50% had a 
VF below 80% and the median of the VF was 80% (IQR 33%). In Nigeria it was 
not possible to estimate the VF due to a lack of data. Two DQAs showed VFs 
above 100%, indicating under-reporting (the deviation from 100% was marginal: 
100.2% and 106.4%). 
VF 95% confidence intervals (CI) were wide, especially in countries with low 
VFs, reflecting the great variability of the DTP3 recounted-reported quotient 
among districts. DQAs with VFs above 95% showed very narrow CIs, 
suggesting homogeneity in the VFs among districts. There was a significant 
correlation between VFs and the widths of its CIs (rho = -0.679, p < 0.001). 
Table  shows a selection of the questions to assess the quality of the 
immunisation reporting system in each tier, with the percentage of countries, 
districts and HUs that correctly answered them, excluding DQAs with a high 
proportion of unreachable districts. 
In theory, immunisation reporting mechanisms can be integrated within the 
national health management information systems or can be set apart as a 
parallel vertical reporting system only for immunisation. DQAs showed that 
reporting of immunisation data from the HU to the district level was integrated in 
61% of the DQAs; and from the district to the national level in 55% of DQAs. 
Computers to manage immunisation data were used in all national 
immunisation programme offices and in 41% of district offices. In almost three 
quarters of the DQAs, immunisation data was used to provide feed-back from 
the national to the district immunisation offices; slightly more than half of 
districts provided feed-back to the HUs under their catchment area. 
Immunisation data was also compiled in some type of publication in 82% of 
national immunisation offices and 58% of districts. However, immunisation 
monitoring charts or tables could only be seen in less than half of the national 
immunisation offices, 59% of districts and in a smaller proportion of HUs. DTP1-
3 drop-out rates were monitored in a lesser proportion at all three levels. A 
relatively high proportion of HUs had some immunisation reports or primary 
recording forms available, but only two thirds had a complete set of reports from 
the previous year. 
The use of consistent denominators is essential to obtain accurate 
immunisation coverage figures. Almost all national immunisation programmes 
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used different figures in different years, reflecting the change in population size. 
However this was not the case in Districts with 87% using the same figures in 
different years.  In 82% of the DQAs, denominators complied with the WHO 
recommended definition. In only 14% of the DQAs it was found that districts 
were using consistent denominators to those assigned by the national 
immunisation programmes to each district within a country. 
The presence of guidelines for different immunisation related procedures was 
variable. At district level, guidelines seemed to be more available than at 
national level. 
Vaccine ledgers to manage vaccine stocks could be found in the majority of 
national immunisation programmes, in district offices and HUs holding vaccine 
stocks, however, a smaller proportion were updated. Vaccine wastage 
calculations could be confirmed in almost one third of national programmes and 
district offices and in two thirds of HUs.  
The answers to these questions were used to estimate QS for each level of the 
immunisation reporting system. The median QS at national level was 3.3 out of 
5.0 (inter-quartile range 0.7), 3.3 out of 5.0 (inter-quartile range 1.1) in the 152 
districts and 3.1 out of 5.0 (inter-quartile range 1.6) in the 912 HUs across all 
districts and countries. 
Correlation analyses 
Figure 2 is a scatter chart depicting one ‘bubble’ per DQA, with the X and Y axis 
showing the aggregated HU and district QSs, respectively. The size of the 
‘bubbles’ is proportional to the QS measured at national immunisation 
headquarters. 
There was a significant correlation between QSs measured at HU and at district 
levels (rho = 0.865, p < 0.001). Larger ‘bubbles’ tended to be found towards the 
upper right corner of the chart suggesting a significant correlation of national 
QSs with district and HUs scores (rho = 0.525, p < 0.001 and rho = 0.4843, p = 
0.002, respectively). 
Figure 2 identifies countries with consistent poor or good performances. Central 
African Republic, Haiti, Lao, Madagascar, Mauritania, Mozambique and Nigeria 
are in the lower left corner with small size bubbles: showing poor QS at all 
levels. At the far right upper end, Tanzania, Burkina Faso, Guinea (second 
DQA) and Kenya (second DQA) show the highest scores (DQAs with a high 
proportion of unreachable districts, excluded). 
We also explored to what extent there could be examples of good quality 
districts (good district QS) in the poorest performing countries (poor national 
QS). QSs at national level significantly correlated with those of the best 
performing district in each country (rho = 0.408, p = 0.004). Looking at pairs of 
national-QS and best district QS in that country data, there were several cases 
of outstanding performance at district level in countries with very poor national 
QSs (Ethiopia, Tajikistan and Yemen) and also cases of consistent poor 
national QSs with even the best districts also poorly performing (Central African 
Republic, Haiti, Madagascar, Mauritania and Nigeria).  
The VF did not show any significant correlation with national QS (rho = 0.211, p 
= 0.202). On the contrary, there were significant correlations with districts and 
HUs QS (rho = 0.703, p < 0.001 and rho = 0.726, p < 0.001 respectively). 
.(DQAs with a high proportion of unreachable districts, excluded). 
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Countries with two DQAs 
From the 21 countries that failed the first DQA, six countries undertook a 
second DQA, two to three years later: Burkina Faso, Cameroon, Guinea, 
Kenya, Madagascar and Sudan. Data from the second DQA in Sudan has to be 
interpreted with caution since 25% of districts were unreachable.Table 2 
summarises the changes in VFs and QSs between both DQAs in each country. 
VFs improved in all cases. 95% CI narrowed in all cases except Cameroon. 
However, first and second DQAs’ VFs overlapped in all countries except 
Madagascar, suggesting that the true values of the VFs may actually not differ.  
At national level, the median change of QS across the six countries was +0.7. 
Looking at some examples of improvement: five of the six countries could 
estimate vaccine wastage in the second DQA while none of them could in the 
first one; in the second DQA, four countries had guidelines for electronic data 
management and for reporting AEFI while only one and none had them in the 
first one, respectively.  
At district level, the median change of the QS was +1.1.  In all six countries, 
districts showed better use of immunisation performance monitoring tools 
(tables and charts showing coverage), better vaccine record keeping and had 
guidelines in place for late reporting. 
At HU level, the median change of the QS was +2.0. HU QS improved 
statistically significantly in all six countries (see Table 3). Quality items that 
improved in all cases included the management of vaccine ledgers, the 
availability of reports and tally sheets and the display of an updated chart or 
table showing immunisation performance indicators. 






Sources of bias in the estimation of immunisation coverage have been widely 
described elsewhere and include inconsistencies in the reporting systems 
(WHO 2006), which DQAs detect through the VF. Poor information systems do 
not only fail to portray the real situation of immunisation coverage but are 
themselves barriers for scaling-up immunisation (GAVI 2003a, Papania M, 
Rodewald 2006,). 
The VF expresses the deviation of national coverage estimates from their 
sources at HUs, where immunisations take place and the primary data is 
recorded in the first instance. These deviations can be partially explained by 
some of the findings in the systems quality questions. For example, there were 
missing primary records and reports (how many of these ever existed?) or 
guidelines for late reporting were frequently not found (how is information 
received after the termination of the reporting period actually treated?). The 
same problem was found when vaccine wastage could not calculated. These 
findings highlight basic problems in the production, storage and reporting of 
immunisation data in countries with poor VFs. Not surprisingly, VF correlated 
well with QS at HU and district levels, which are the sources of primary 
immunisation data. 
Guidelines and training manuals on immunisation, which include monitoring and 
data management, are easily available (WHO 2004a) and extensive training 
has taken place in many countries (Mutabaruka at al. 2005). Why, then, do the 
basic administrative and reporting practices seem not to have been followed in 
those countries with poor DQA outcomes? Many determinants of performance 
at sub-national and local levels have been described (Mays et al. 2006), 
including remuneration, working conditions and factors directly related to health 
workers performance (Rowe et al. 2005). Whether this is pointing at a lack of 
knowledge or a poor organisational environment is beyond what DQAs can 
answer. However, we think that training on immunisation issues will need to 
take into account the basics of recording, reporting and data management 
practices and look in detail at the organisational environment needed to 
translate knowledge into effective, routine practice. 
Countries 
The best performing countries achieved excellent VFs and QSs. Central African 
Republic, low in all QS, had a good VF. At the other extreme, Haiti, 
Madagascar, Mauritania and Nigeria showed consistently poor performance at 
all levels of the immunisation reporting system. 
Should poor performing countries be penalised without additional funding under 
a performance-based system, as it has been the case with GAVI’s rewards? 
(GAVI 2006). Could a system aiming at rewarding performance and ensuring 
transparency end up having adverse effects on those countries in most need of 
help? Would countries facing a performance-based system feel tempted to 
generate some ‘creative’ reporting to increase rewards (Brugha R et al.) or to 
redirect their efforts to increase overall coverage rather than reducing in-country 
inequities (Starling et al. 2006)?. The answers to these questions are not 
straightforward. First, there are multiple factors which determine immunisation 
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performance, including health system and contextual factors; secondly, in real 
life situations it is hardly possible to have “control” countries to establish sound 
comparisons in order to describe key determinants of success or failure. Our 
findings, though, identified several countries that showed consistent poor 
performance and that may call for special attention. Nigeria, for example, was 
the only country where the VF could not even be calculated due to the lack of 
data, it has one of highest numbers of unimmunised children in the world (WHO 
2006) and had more than half the cases of polio in 2006 (Global Polio 
Eradication Initiative). GAVI has wisely responded to those concerns by 
considering separate policies for “fragile states” (Brugha R et al.).  
Furthermore, districts within countries showed very different performance levels 
in the DQAs outcomes, suggesting that, besides nation-wide factors, there 
might be local determinants that may contribute to find very good performing 
districts in not so good performing countries, as seen in the cases of Ethiopia or 
Tajikistan. 
 
DQAs as inducers of change 
DQAs are an assessment tool. However, one of the outcomes of DQAs is the 
issuing of recommendations to assist HUs, districts and national immunisation 
programmes to improve their reporting systems (GAVI 2003b). Therefore, 
DQAs aim to induce change, as well. 
Neither the design of DQAs nor the number of countries that undertook two 
DQAs can generate enough evidence to attribute the observed improvements to 
the DQAs themselves. However, in those countries that undertook two DQAs, 
improvements in the VFs were consistent with improvements in the QS, and 
showed statistically significant changes in the QSs at HU level. These 
improvements could be due to a ‘learning effect’ of the DQA method by 
countries, although districts and HUs in both DQAs were randomly selected and 
repetitions are very unlikely. DQAs certainly were an opportunity to raise quality 
issues and increase awareness on the consequences of poor data quality for 
programme management. Indeed, there is some evidence that failure to ‘pass’ a 
DQA has led to specific efforts (e.g. investment) in reporting information 
systems in a number of countries (Guinea, Laos, Tanzania and Zambia) (Abt 
Associates Inc. 2007).  
DQAs have a number of limitations (Ronveaux et al. 2005), some of them 
analysed in detail (Woodard et al. 2007); namely the wide CI of the VF, more 
imprecise at the medium and low ranges of the VF, the lack of verification of 
immunisations actually administered to children and the number of non-eligible 
districts in a few countries.  
 
Conclusion 
DQA is a systematic methodology to describe in depth data quality issues and 
to provide recommendations to address them. DQAs can reveal a number of 
crucial problems that affect the quality of immunisation data and provide 
countries with an opportunity to identify the weakest parts in the collection, 
transmission and use of information. Basic recording and reporting practices at 
the periphery of the system, alongside design aspects (e.g. denominators), 
have been identified as key factors that need to be tackled. DQAs also provide 
insights from all tiers of the health system, identifying good practices in some 
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HUs and districts even in countries poorly performing as a whole. Those HUs 
and districts can become drivers to improve reporting mechanisms in the 
countries. DQAs have been adapted into a self-assessment tool (WHO 2004b) 
and can be simplified to assess specific aspects of the information system. In 
whatever form, DQAs bring data quality issues to the top front of the agenda to 
improve the monitoring of immunisation coverage. Furthermore, the DQA 
methodology could be considered to address data quality issues across the 
spectrum of national disease control programmes (The Global Fund 2007) so 
data quality remains at the top of the national agenda to help improve planning 
and service delivery based on accurate coverage estimates. 
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Table 1. Country profiles and DQA framework 

















Africa Burkina Faso BFA 53 504 211  2 2001, 2004 48 
 Burundi BDI 17 260 91  1 2002 24 
 Cameroon CMR 144 663 579  2 2001, 2003 45 
 Central African Republic CAF 22 134 281  1 2003 24 
 Chad TCD 53 302 437  1 2004 24 
 Congo COG 27 148 780  1 2004 24 
 Congo DR COD 481 2,245 111  1 2003 24 
 Côte d'Ivoire CUV 46 674 594  1 2001 24 
 Eritrea ERI 6 107 210  1 2003 24 
 Ethiopia ETH 71 2,352 99  1 2001 23 
 Ghana GHA 120 756 256  1 2001 21 
 Guinea GIN 38 329 345  2 2001, 2003 44 
 Kenya KEN 85 1,158 353  2 2001, 2003 48 
 Lesotho LSO 19 48 736  1 2003 24 
 Liberia LBR 18 118 121  1 2004 24 
 Madagascar MDG 111 599 252  2 2002, 2004 48 
 Mali MLI 58 421 241  1 2001 24 
 Mauritania MRT 53 113 390  1 2003 23 
 Mozambique MOZ 12 689 198  1 2001 14 
 Niger NER 42 550 158  1 2002 24 
 Nigeria NGA NA 5,054 345  1 2002 24 
 Rwanda RWA 39 338 195  1 2001 22 
 Senegal SEN 50 429 447  1 2002 24 
 Sierra Leone SLE 14 219 193  1 2003 24 
 Sudan SDN 129 1,001 365  2 2001, 2003 46 
 Tanzania TZA 135 1,377 271  1 2001 24 
 Togo TGO 35 199 295  1 2003 21 
 Uganda UGA 64 1,022 224  1 2001 24 
 Zambia ZMB 72 425 319  1 2002 24 
 Zimbabwe ZWE 59 365 387  1 2003 24 
Asia Afghanistan AFG 32 943 141  1 2002 24 
 Bangladesh BGD 64 3,202 389  1 2001 24 
 Cambodia KHM 73 412 256  1 2002 24 
 Korea DPR PRK 206 420 579  1 2003 24 
 Lao PDR LAO 18 159 315  1 2002 24 
 Myanmar MMR 320 1,350 191  1 2003 24 
 Nepal NPL 75 737 221  1 2002(‡) 24 
 Pakistan PAK 115 5,262 498  1 2002 24 
 Tajikistan TJK 62 161 158  1 2001 19 
 Yemen YEM 286 599 498  1 2002 20 
Caribbean Haiti HTI 11 286 457  1 2001 16 
TOTALS 41 Countries 3,335 36,130 -   47 - 1,082 
MEAN PER COUNTRY   83 881 322   - - 26 
Data on regions, countries (UNa, UNb) and per capita GNI (UNc) were obtained from official United 
Nations statistics. (*)Gross National Income per capita in US Dollars; (†) Proportion of funds provided by 
the governments for financing the Expanded Programme of Immunisation (data for year 2004); (‡) Audit 
year 2001-2002.  
 




Table 2. Performance in a selection of quality questions at the three levels 
Quality question % of the 38 DQAs 
% of the 152 
districts 
% of 912 
HUs 
Integration of immunisation reporting systems 
from HUs to district level 61% NA(║) NA 
Integration of immunisation reporting systems 
from district to national level 55% NA NA 
    
Use of computers to manage immunisation data 100% 41% NA 
Feed-back on immunisation to lower level 71% 53% NA 
Publication with immunisation data 82% 58% NA 
Existence of chart or table showing immunisation 
performance indicators 45% 59% 53% 
Monitoring DPT1-3 drop out rate 35%(*) 46%(†) 55%(‡) 
Availability of current tally sheets for DPT NA NA 82% 
Availability of reports NA NA 65% 
    
Use of different denominators according to year 
to estimate DTP3 coverage 97% 87% NA 
Denominators for DTP3 defined according to 
WHO definitions 82% NA NA 
Denominators used at national and district levels 
coincide 14%(*) NA NA 
    
Existence of data reporting guidelines 74% 89% NA 
Existence of guidelines to deal with late reporting 13% 50% NA 
Existence of guidelines to report AEFI(§) 32% 54% 83% 
Existence of vaccine ledgers NA 88% 85% 
Vaccines ledgers are up to date for DTP 79% 72% 65%(‡) 
Vaccines ledgers are up to date for TT(**) 84% 75% 49% 
Correct estimation of vaccine wastage 32% 31% 68% 
 
(*) In 23 DQAs; (†) in 92 districts; (‡) in 552 HUs. (§) AEFI: Adverse Events Following 
Immunisation. (║) NA: not assessed at that level. (**) Tetanus Toxoid vaccine. 
 
 




Table 3. Compared performance of countries that undertook two DQAs 
Countries Year   Verification factor   Quality Scores 
  DQAs   95% CI National Distrital HU  
 2001  58% 19% 96%  3.2 3.3 2.5   
Burkina Faso 2004  96% 81% 111%   3.9 4.3 4.4   
  Change   +38%       +0.7 +1.0 +1.9 (*) 
 2001  48% 15% 81%  3.6 2.9 2.1   
Cameroon 2003  89% 53% 125%  4.3 4.4 4.1  
  Change   +41%       +0.7 +1.5 +2.0 (*) 
 2001  57% 1% 113%  3.0 3.3 3.5   
Guinea 2003  95% 92% 99%  3.4 4.2 4.5  
  Change   +38%       +0.4 +0.9 +1.0 (*) 
 2001  50% 8% 91%  3.4 3.1 2.3   
Kenya 2003  85% 68% 103%  4.0 4.1 4.3  
  Change   +35%       +0.6 +1.0 +2.0 (*) 
 2002  58% 42% 75%  2.4 2.7 2.3   
Madagascar 2004  100% 83% 117%  3.5 4.4 4.0  
  Change   +42%       +1.1 +1.7 +1.7 (*) 
 2001  69% 18% 121%  2.6 2.7 2.1   
Sudan 2003  96% 89% 103%  4.5 3.9 4.1  
  Change   +27%       +1.9 +1.2 +2.0 (*) 
CI: confidence interval; (*) p < 0.001 comparing the median QS of the 24 HUs in both years. 
 





Figure 1. Verification factors (VF) and DTP3 coverage (WHO-UNICEF) in 




CI: confidence intervals. VF: Verification Factor. Solid squares: African countries and Haiti; 
empty squares: Asian countries and Yemen. 









Good correlation between QS is shown by many ‘bubbles” lying relatively close to the diagonal 
of the chart and their size growing from the lower-left up to the upper-right corners. 
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